DarioHealth
DarioHealth

DarioHealth

Health Care Technology
WebsiteInvestor RelationsSEC
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

$67.2M

Market Cap • 9/11/2026

2011

(15 years)

Founded

2013

(13 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,2

P/S

3,2

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

8,2

EPS

—

Market Cap

Market Cap

67,2M

EV

85,7M

EV/Revenue

4,1

EV/EBITDA

-2,9

EV/EBIT

-2,7

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-468,3M

Profitability

Gross Margin

58,2%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

49,8%

Capex/Revenue

0,6%

Capex/D&A

6,4%

Capex/OCF

-0,5%

SBC/OCF

—

% PPE

1,6%

% Goodwill

59,5%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

10,1%

CAGR Op. Income 5Y

-16,1%

CAGR Net Income 5Y

-14,1%

CAGR EPS 5Y

-39,2%

CAGR OCF 5Y

-5,4%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

2,3

Quick Ratio

1,6

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium